Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Licaminlimab by Oculis for Anterior Uveitis: Likelihood of Approval
Licaminlimab is under clinical development by Oculis and currently in Phase II for Anterior Uveitis. According to GlobalData, Phase II...
Dexamethasone acetate by Oculis for Ocular Pain (Eye Pain): Likelihood of Approval
Dexamethasone acetate is under clinical development by Oculis and currently in Phase III for Ocular Pain (Eye Pain). According to...
Dexamethasone acetate by Oculis for Ocular Inflammation: Likelihood of Approval
Dexamethasone acetate is under clinical development by Oculis and currently in Phase III for Ocular Inflammation. According to GlobalData, Phase...
Risk adjusted net present value: What is the current valuation of Oculis's Licaminlimab?
Licaminlimab is a monoclonal antibody commercialized by Oculis, with a leading Phase II program in Anterior Uveitis. According to Globaldata,...
Licaminlimab by Oculis for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Licaminlimab is under clinical development by Oculis and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...